Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease

Fourteen slightly disabled patients with Parkinsonism were treated separately with benzhexol, amantadine, and levodopa. Benzhexol and amantadine both gave a 15% reduction in functional disability and levodopa a 36% reduction. Benzhexol lessened the rigidity and improved the flexion of posture of Parkinson's disease, but had little or no effect on akinesia and tremor. Amantadine and levodopa caused improvement in all these symptoms. The combination of benzhexol and amantadine was as effective after four weeks of treatment as levodopa was after six months.

[1]  T. Svensson,et al.  On the mode of action of amantadine , 1970, The Journal of pharmacy and pharmacology.

[2]  R. Duvoisin.  Cholinergic-anticholinergic antagonism in parkinsonism. , 1967, Archives of neurology.

[3]  G C Cotzias,et al.  Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.

[4]  P. Flatberg.  [Amantadine for parkinsonism]. , 1970, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[5]  M. Eadie,et al.  THE CONTINUED USE OF AMANTADINE HYDROCHLORIDE IN PARKINSONISM , 1971, The Medical journal of Australia.

[6]  M. Besson,et al.  Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. , 1970, European journal of pharmacology.

[7]  U. Ungerstedt,et al.  Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease. , 1971, European journal of pharmacology.

[8]  R. Schwab,et al.  Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. , 1969, Transactions of the American Neurological Association.

[9]  R. Knill-Jones,et al.  L-dopa and amantadine hydrochloride in Parkinson's disease. , 1971, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology.

[10]  R. Duvoisin.  A REVIEW OF DRUG THERAPY IN PARKINSONISM. , 1965, Bulletin of the New York Academy of Medicine.

[11]  T. Taylor,et al.  Great-toe Extensor Reflexes in the Diagnosis of Lumbar Disc Disorder , 1969, British medical journal.

[12]  J. Polgár,et al.  Levodopa in Parkinsonism: the Effects of Withdrawal of Anticholinergic Drugs , 1971, British medical journal.

[13]  C. Marsden,et al.  Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase , 1973, Journal of neurology, neurosurgery, and psychiatry.

[14]  D. Laplane,et al.  [Amantadine. Prolonged clinical trial in 50 parkinsonian patients]. , 1972, La Nouvelle presse medicale.

[15]  J. Reid,et al.  Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa , 1971, British medical journal.

[16]  Schwab Rs,et al.  Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. , 1969 .